141 related articles for article (PubMed ID: 35017351)
1. Successful chemotherapy with liposomal doxorubicin for metastatic Kaposi's sarcoma without skin involvement in the kidney transplant recipient.
Kozak S; Gładyś A; Karkoszka H; Pająk J; Wdowiak K; Chudek J
Saudi J Kidney Dis Transpl; 2021; 32(2):548-553. PubMed ID: 35017351
[TBL] [Abstract][Full Text] [Related]
2. Bilateral eyelid Kaposi's sarcoma in an HIV-negative patient.
Fernández-Montalvo L; Ibáñez-Flores N; Cifuentes-Canorea P; Castellar-Cerpa J; Graell-Martín X; Cuadrado-Claramonte V
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):606-609. PubMed ID: 30055902
[TBL] [Abstract][Full Text] [Related]
3. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation].
Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G
G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371
[TBL] [Abstract][Full Text] [Related]
5. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.
Duggan ST; Keating GM
Drugs; 2011 Dec; 71(18):2531-58. PubMed ID: 22141391
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Chemotherapy of AIDS-Related Kaposi's Sarcoma: A Meta-Analysis.
Liu R; Zhou J; Yang S; Zhang Z
Am J Ther; 2018; 25(6):e719-e721. PubMed ID: 29509553
[No Abstract] [Full Text] [Related]
7. Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
Kreuter A; Rasokat H; Klouche M; Esser S; Bader A; Gambichler T; Altmeyer P; Brockmeyer NH
Cancer Invest; 2005; 23(8):653-9. PubMed ID: 16377582
[TBL] [Abstract][Full Text] [Related]
8. Kaposi sarcoma after kidney transplantation.
Raedemaeker J; Marot L; Camboni A; Kanaan N
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31061183
[No Abstract] [Full Text] [Related]
9. Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.
Dalu D; Fasola C; Ammoni L; De Francesco D; Cona MS; Rota S; Ferrario S; Gambaro A; Tosca N; Piva S; La Verde N
J Chemother; 2021 Sep; 33(5):342-347. PubMed ID: 34060438
[TBL] [Abstract][Full Text] [Related]
10. Role of pegylated lyposomal doxorubicin (PLD) in systemic Kaposi's sarcoma: a systematic review.
Di Trolio R; Di Lorenzo G; Delfino M; De Placido S
Int J Immunopathol Pharmacol; 2006; 19(2):253-63. PubMed ID: 16831292
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
Coukell AJ; Spencer CM
Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
[TBL] [Abstract][Full Text] [Related]
12. Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.
Volkow P; Lizano M; Carrillo-García A; Pérez-Montiel D; Garciadiego P
AIDS; 2014 Sep; 28(15):2327-9. PubMed ID: 25313589
[No Abstract] [Full Text] [Related]
13. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.
Parravicini C; Olsen SJ; Capra M; Poli F; Sirchia G; Gao SJ; Berti E; Nocera A; Rossi E; Bestetti G; Pizzuto M; Galli M; Moroni M; Moore PS; Corbellino M
Blood; 1997 Oct; 90(7):2826-9. PubMed ID: 9326251
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
Verucchi G; Calza L; Trevisani F; Zambruni A; Tadolini M; Giuliani R; Manfredi R; Andreone P; Chiodo F; Bernardi M
Transpl Infect Dis; 2005 Mar; 7(1):34-7. PubMed ID: 15984947
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient.
Nair V; Sheikh F; Hirschwerk D; Fahmy A; Bhaskaran M; Grodstein E; Winnick A; Maki R; Teperman L; Molmenti E
Transpl Infect Dis; 2019 Oct; 21(5):e13132. PubMed ID: 31220395
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient.
Fu W; Merola J; Malinis M; Lacy J; Barbieri A; Liapakis AH; Mulligan DC; Yoo PS
Transpl Infect Dis; 2018 Oct; 20(5):e12966. PubMed ID: 30014622
[TBL] [Abstract][Full Text] [Related]
19. Primary Kaposi sarcoma of the subcutaneous tissue.
Pantanowitz L; Mullen J; Dezube BJ
World J Surg Oncol; 2008 Sep; 6():94. PubMed ID: 18764944
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
